Reconsidering the management of patients with cancer with viral hepatitis in the era of immunotherapy

In the evolving immune-oncology landscape, numerous patients with cancer are constantly treated with immune checkpoint inhibitors (ICPIs) but among them, only sporadic cases with pre-existing hepatitis B virus (HBV) and hepatitis C virus (HCV) are recorded. Despite the global dissemination of HBV an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunother Cancer
Main Authors: Ziogas, Dimitrios C, Kostantinou, Frosso, Cholongitas, Evangelos, Anastasopoulou, Amalia, Diamantopoulos, Panagiotis, Haanen, John, Gogas, Helen
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2020
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7570225/
https://ncbi.nlm.nih.gov/pubmed/33067316
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-000943
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados